Bausch Health Companies | Capitaux D'Emprunt



Loan Capital Changement Date
Amgen USD 56.55B 305M 2024-12
ANI Pharmaceuticals USD 614.92M 302M 2024-12
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.23B 2.29B 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Danaher USD 15.98B 476M 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
Novo Nordisk 51.45B 156M 2024-09
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Prestige Brands USD 996.05M 55.67M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 5.22B 1.35B 2024-12



Bausch Health Companies Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.